Marcus L. O. Penido - Concepedia

Author

Marcus L. O. Penido

Also Known As

Marcus L O Penido, Marcus L. O. Penido, Marcus L. Penido, Marcus L.O. Penido, Marcus Luiz O Penido, Marcus Luiz Oliveira Penido

Publications

595

Citations

H-Index

Concepts

All Affiliations

Universidade Federal de Minas Gerais Fundação Oswaldo Cruz Universidade Federal de São Paulo University of Massachusetts Chan Medical School Universidade Federal de Juiz de Fora

About

Marcus L. O. Penido is an author at Universidade Federal de Minas Gerais specializing in medicine, immunology, and t cell immunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	178
2	Allergy	2	2	88
3	Natural Sciences	1	1	38
4	Biochemistry	1	1	38
5	Cell Biology	1	1	37

Marcus L. O. Penido

Publications

583

Citations

H-Index

Page 1

	Year	Citations
Distinct Kinetics of Effector CD8<sup>+</sup>Cytotoxic T Cells after Infection with<i>Trypanosoma cruzi</i>in Naive or Vaccinated Mice Fanny Tzelepis, Bruna Cunha de Alencar, Marcus L. O. Penido, Infection and Immunity	2006	100
Infection with <i>Trypanosoma cruzi</i> Restricts the Repertoire of Parasite-Specific CD8+ T Cells Leading to Immunodominance Fanny Tzelepis, Bruna Cunha de Alencar, Marcus L. O. Penido, The Journal of Immunology	2008	88
CD8<sup>+</sup>-T-Cell-Dependent Control of<i>Trypanosoma cruzi</i>Infection in a Highly Susceptible Mouse Strain after Immunization with Recombinant Proteins Based on Amastigote Surface Protein 2 Adriano Fernando Araújo, Bruna Cunha de Alencar, José Ronnie Vasconcelos, Infection and Immunity	2005	68
Epitope mapping and protective immunity elicited by adenovirus expressing the Leishmania amastigote specific A2 antigen: Correlation with IFN-γ and cytolytic activity by CD8+ T cells Daniela de Melo Resende, Bráulia Costa Caetano, Míriam Santos Dutra, Vaccine Cytolytic ActivityAllergyImmune RegulationImmunologyImmunodominance	2008	67
High-Throughput Analysis of Synthetic Peptides for the Immunodiagnosis of Canine Visceral Leishmaniasis Angélica Rosa Faria, Míriam Maria Silva Costa, Mário S. Giusta, PLoS neglected tropical diseases	2011	56
Vaccination with Replication-Deficient Recombinant Adenoviruses Encoding the Main Surface Antigens of <i>Toxoplasma gondii</i> Induces Immune Response and Protection Against Infection in Mice Bráulia Costa Caetano, Oscar Bruña–Romero, Blima Fux, Human Gene Therapy	2006	51
A new series of schistosomicide drugs, the alkylaminoalkanethiosulfuric acids, partially inhibit the activity of Schistosoma mansoni ATP diphosphohydrolase Marcus L. O. Penido, Dayse Moura Resende, Marco A. Vianello, European Journal of Pharmacology Medicinal ChemistryBiosynthesisBioorganic ChemistryBiochemistryAntiparasitic Agent	2007	38
Cross-priming of long lived protective CD8+ T cells against Trypanosoma cruzi infection: Importance of a TLR9 agonist and CD4+ T cells Bruna Cunha de Alencar, Adriano Fernando Araújo, Marcus L. O. Penido, Vaccine Tlr9 AgonistAutoimmune DiseaseAfrican TrypanosomiasisTrypanosoma Cruzi InfectionImmunology	2007	37
Trypanosoma cruzi Adjuvants Potentiate T Cell-Mediated Immunity Induced by a NY-ESO-1 Based Antitumor Vaccine Caroline Junqueira, Ana Tereza Gomes Guerrero, Bruno Galvão-Filho, PLoS ONE	2012	32
MyD88-dependent protective immunity elicited by adenovirus 5 expressing the surface antigen 1 from Toxoplasma gondii is mediated by CD8+ T lymphocytes Érica Araújo Mendes, Bráulia Costa Caetano, Marcus L. O. Penido, Vaccine AllergyPathogenesisImmunologyAdenovirus 5Autoimmunity	2011	21

Page 1